Comparative effectiveness of androgen receptor pathway inhibitor treatment intensification for metastatic hormone-sensitive prostate cancer in real-world patients
Investigative and Clinical Urology · 2025
DOI: 10.4111/icu.20250313 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Investigative and Clinical Urology, 2025. Verfasst von Chan Ho Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea. Hauptthemen laut MEDLINE: Phenylthiohydantoin, Abiraterone Acetate, Thiohydantoins, Androgen Receptor Antagonists. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Busan Paik Hospital, Inje University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.
- Department of Urology, Dong-A University College of Medicine, Busan, Korea.
- Department of Urology, Dongnam Institute of Radiological & Medical Sciences Korea Cancer Center Hospital, Busan, Korea.
- Department of Urology, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.
- Biomedical Research Institute, Pusan National University Hospital, Busan, Korea. hongkooha@pusan.ac.kr.
ORCID-Profile: Chan Ho Lee, Soodong Kim, Ja Yoon Ku, Kyung Hwan Kim, Byeong Jin Kang, Hyeok Jun Goh, Won Ik Seo, Hong Koo Ha
Förderung
- Busan Paik Hospital, Inje University
Zitieren
APA
Lee, C. H., Kim, S., Ku, J. Y., Kim, K. H., Kang, B. J., Goh, H. J., Seo, W. I., & Ha, H. K. (2025). Comparative effectiveness of androgen receptor pathway inhibitor treatment intensification for metastatic hormone-sensitive prostate cancer in real-world patients. Investigative and Clinical Urology. https://doi.org/10.4111/icu.20250313
Vancouver
Lee CH, Kim S, Ku JY, Kim KH, Kang BJ, Goh HJ, et al. Comparative effectiveness of androgen receptor pathway inhibitor treatment intensification for metastatic hormone-sensitive prostate cancer in real-world patients. Investigative and Clinical Urology. 2025. doi:10.4111/icu.20250313
BibTeX
@article{Lee2025,
author = {Lee, Chan Ho and Kim, Soodong and Ku, Ja Yoon and Kim, Kyung Hwan and Kang, Byeong Jin and Goh, Hyeok Jun and Seo, Won Ik and Ha, Hong Koo},
title = {Comparative effectiveness of androgen receptor pathway inhibitor treatment intensification for metastatic hormone-sensitive prostate cancer in real-world patients},
journal = {Investigative and Clinical Urology},
year = {2025},
doi = {10.4111/icu.20250313}
}
EUVIMED